Exec Director, Viral Vector Process Development

Role: Lead end-to-end viral vector development for cell and gene therapies, focusing on scalable platforms supporting clinical to commercial manufacturing. Responsibilities: define technical strategy for lentiviral vectors (LVV), oversee process development (upstream/downstream), drive process scale-up, tech transfer, and next-generation innovations including in vivo vectors. Collaborate with Research, Product, Analytical, and Manufacturing teams to optimize vector design, performance, and regulatory readiness. Requirements: PhD in Biochemical Engineering, Molecular Biology, Virology, or related field with 15+ years in viral vector development, especially LVV or RVV; extensive experience in manufacturing support, process development, and regulatory compliance within cell/gene therapy. Preferred: exposure to in vivo gene delivery platforms, CMC experience, and leadership in matrixed environments. High-Value: Expertise in lentiviral vector design, process development, and commercialization; experience supporting CAR T-cell therapy programs; knowledge of cGMP regulations, regulatory interactions, and process validation. Location: Santa Monica or Oceanside, CA, on-site required. The role demands executive influence, strategic leadership, and talent development in a highly matrixed, innovative, fast-paced environment.